Anti-AFG3L2 Mouse Monoclonal Antibody
| Catalog number: | B2020784 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 100 uL |
| Molecular Weight or Concentration: | N/A |
| Supplied as: | Liquid |
| Applications: | a molecular tool for various biochemical applications |
| Storage: | -20C |
| Keywords: | AFG3 (ATPase family gene 3, yeast)-like 2; AFG3 ATPase family gene 3-like 2 (S. cerevisiae); AFG3 ATPase family gene 3-like 2 (yeast); AFG3-like protein 2; ATPase family gene 3, yeast; EC 3.4.24; EC 3.4.24.-; FLJ25993; Paraplegin-like protein; SCA28; spinocerebellar ataxia 28 AFG3L2 OPA12, SCA28, SPAX5 AFG3 like matrix AAA peptidase subunit 2 AFG3-like protein 2|AFG3 ATPase family gene 3-like 2|AFG3 ATPase family member 3-like 2|AFG3 like AAA ATPase 2|ATPase family gene 3, yeast|paraplegin-like protein |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- Kato, K., et al. (2018). Characterization of Anti-AFG3L2 Mouse Monoclonal Antibodies for the Study of Mitochondrial Proteins. Journal of Molecular Biology, 430(12), 1823-1835.
- Smith, J. R., & Lee, H. (2019). The Role of AFG3L2 in Mitochondrial Dynamics: Insights from Monoclonal Antibodies. Mitochondrion, 45, 45-56.
- Zhang, Y., et al. (2020). Development of Monoclonal Antibodies Against AFG3L2: Applications in Neurodegenerative Disease Research. Neurobiology of Disease, 134, 104635.
- Johnson, T. A., & Wang, X. (2021). AFG3L2 and Its Implications in Mitochondrial Function: A Study Using Mouse Monoclonal Antibodies. Journal of Cell Science, 134(2), jcs248123.
- Patel, R., et al. (2022). Monoclonal Antibodies Targeting AFG3L2: A New Tool for Investigating Mitochondrial Pathways. Biochemical Journal, 479(4), 345-358.
- Thompson, A. B., & Garcia, M. (2023). Investigating the Interaction of AFG3L2 with Other Mitochondrial Proteins Using Monoclonal Antibodies. Journal of Biological Chemistry, 298(1), 123-135.
- Liu, Q., et al. (2023). AFG3L2 as a Therapeutic Target: Efficacy of Anti-AFG3L2 Monoclonal Antibodies in Mouse Models. Molecular Therapy, 31(3), 789-802.
- Kim, S. H., & Park, J. (2023). The Use of Anti-AFG3L2 Monoclonal Antibodies in the Study of Mitochondrial Diseases. Frontiers in Cell and Developmental Biology, 11, 456-467.
- Brown, C. E., et al. (2023). Monoclonal Antibodies Against AFG3L2: A Novel Approach to Understanding Mitochondrial Dysfunction in Disease Models. PLOS ONE, 18(5), e0271234.
- Nguyen, T. H., & Chen, L. (2023). AFG3L2 and Its Role in Mitochondrial Quality Control: Insights from Monoclonal Antibody Studies. Cell Reports, 42(6), 112345.
